You are off base as usual, we have almost 7 figures invested here.
We believe in the drug and so do most of the top depression people in the world. Not to mention the National Institute of Health otherwise they would not have 100:/: funded the phase 2a trial.
Biotech’s have huge risks but the rewards can be astronomical.
A novice investor looking at this will figure out the market manipulation here and the huge disconnect between current market cap as opposed to potential reward.
They are underfunded for sure, but that can change with just one fund. Oppenheimer just came in and there will be more.
News 
Market Data 
Discover 
